Department of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
Information Center Department/Department of Information Management, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Front Med. 2024 Apr;18(2):315-326. doi: 10.1007/s11684-023-1014-x. Epub 2023 Nov 22.
This cohort study was performed to explore the influence of intensive care unit (ICU) quality on in-hospital mortality of veno-venous (V-V) extracorporeal membrane oxygenation (ECMO)-supported patients in China. The study involved all V-V ECMO-supported patients in 318 of 1700 tertiary hospitals from 2017 to 2019, using data from the National Clinical Improvement System and China National Critical Care Quality Control Center. ICU quality was assessed by quality control indicators and capacity parameters. Among the 2563 V-V ECMO-supported patients in 318 hospitals, a significant correlation was found between ECMO-related complications and prognosis. The reintubation rate within 48 hours after extubation and the total ICU mortality rate were independent risk factors for higher in-hospital mortality of V-V ECMO-supported patients (cutoff: 1.5% and 7.0%; 95% confidence interval: 1.05-1.48 and 1.04-1.45; odds ratios: 1.25 and 1.23; P = 0.012 and P = 0.015, respectively). Meanwhile, the V-V ECMO center volume was a protective factor (cutoff of ≥ 50 cases within the 3-year study period; 95% confidence interval: 0.57-0.83, odds ratio: 0.69, P = 0.0001). The subgroup analysis of 864 patients in 11 high-volume centers further strengthened these findings. Thus, ICU quality may play an important role in improving the prognosis of V-V ECMO-supported patients.
本队列研究旨在探讨中国重症加强治疗病房(ICU)质量对静脉-静脉(V-V)体外膜肺氧合(ECMO)支持患者院内死亡率的影响。该研究纳入了 2017 年至 2019 年期间来自 1700 家三级医院的 318 家医院中所有接受 V-V ECMO 支持的患者,数据来源于国家临床改善系统和中国国家危重症质量控制中心。通过质量控制指标和能力参数来评估 ICU 质量。在 318 家医院的 2563 例 V-V ECMO 支持患者中,ECMO 相关并发症与预后之间存在显著相关性。拔管后 48 小时内再插管率和 ICU 总死亡率是 V-V ECMO 支持患者院内死亡率较高的独立危险因素(截断值分别为 1.5%和 7.0%;95%置信区间分别为 1.05-1.48 和 1.04-1.45;比值比分别为 1.25 和 1.23;P = 0.012 和 P = 0.015)。同时,V-V ECMO 中心的容量是一个保护因素(3 年研究期间≥50 例的截断值;95%置信区间为 0.57-0.83,比值比为 0.69,P = 0.0001)。对 11 家大容量中心的 864 例患者进行的亚组分析进一步证实了这些发现。因此,ICU 质量可能在改善 V-V ECMO 支持患者的预后方面发挥重要作用。